Summary

The global Musculoskeletal System Disorder market was valued at US$ 147839 million in 2023 and is anticipated to reach US$ 195182 million by 2030, witnessing a CAGR of 4.19% during the forecast period 2024-2030.
North American market for Musculoskeletal System Disorder is estimated to increase from $ 77023 million in 2023 to reach $ 100034 million by 2030, at a CAGR of 3.89% during the forecast period of 2024 through 2030.
Asia-Pacific market for Musculoskeletal System Disorder is estimated to increase from $ 26000 million in 2023 to reach $ 35515 million by 2030, at a CAGR of 4.84 % during the forecast period of 2024 through 2030.

The major global companies of Musculoskeletal System Disorder include AbbVie, Johnson & Johnson, Stryker, Zimmer Biomet, Smith & Nephew, Bristol-Myers Squibb, Medtronic, Arthrex, Haleon, etc. In 2023, the world's top five vendors accounted for approximately 31.46% of the revenue.
This report aims to provide a comprehensive presentation of the global market for Musculoskeletal System Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Musculoskeletal System Disorder.

The Musculoskeletal System Disorder market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Musculoskeletal System Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Musculoskeletal System Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation
By Company
AbbVie
Pfizer
Johnson & Johnson
Haleon
Bayer
Biogen
Novartis
Sanofi
Sarepta Therapeutics
Merck & Co
Nippon Shinyaku
Bristol-Myers Squibb
Roche
UCB
Stryker
Zimmer Biomet
Smith & Nephew
Globus Medical
Medtronic
B Braun
Acumed
Orthofix
Arthrex
MicroPort
WEGO

Segment by Type
Joint Disorder
Bone Disorder
Muscle Disorder
Other

Segment by Application
Hospital & Clinic
Retail Pharmacy
Other

By Region
North America
United States
Canada

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia

Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe

Latin America
Mexico
Brazil
Rest of Latin America

Middle East & Africa
Middle East
Africa

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Musculoskeletal System Disorder company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

ページTOPに戻る

Table of Contents

1 Report Overview 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 Global Musculoskeletal System Disorder Market Size Growth Rate by Type: 2019 VS 2023 VS 2030 1
1.2.2 Joint Disorder 3
1.2.3 Bone Disorder 4
1.2.4 Muscle Disorder 4
1.3 Market by Application 4
1.3.1 Global Musculoskeletal System Disorder Market Growth by Application: 2019 VS 2023 VS 2030 5
1.3.2 Hospital & Clinic 6
1.3.3 Retail Pharmacy 7
1.4 Assumptions and Limitations 8
1.5 Study Objectives 9
1.6 Years Considered 9
2 Global Growth Trends 10
2.1 Global Musculoskeletal System Disorder Market Perspective (2019-2030) 10
2.2 Global Musculoskeletal System Disorder Growth Trends by Region 11
2.2.1 Global Musculoskeletal System Disorder Market Size by Region: 2019 VS 2023 VS 2030 12
2.2.2 Musculoskeletal System Disorder Historic Market Size by Region (2019-2024) 13
2.2.3 Musculoskeletal System Disorder Forecasted Market Size by Region (2025-2030) 14
2.3 Musculoskeletal System Disorder Market Dynamics 14
2.3.1 Musculoskeletal System Disorder Industry Trends 14
2.3.2 Musculoskeletal System Disorder Market Drivers 16
2.3.3 Musculoskeletal System Disorder Market Challenges 17
2.3.4 Musculoskeletal System Disorder Market Restraints 18
3 Competition Landscape by Key Players 19
3.1 Global Top Musculoskeletal System Disorder Players by Revenue 19
3.1.1 Global Top Musculoskeletal System Disorder Players by Revenue (2019-2024) 19
3.1.2 Global Musculoskeletal System Disorder Revenue Market Share by Players (2019-2024) 20
3.2 Global Musculoskeletal System Disorder Market by Company Type (Tier 1, Tier 2, and Tier 3) 22
3.3 Global Key Players Ranking by Musculoskeletal System Disorder Revenue 23
3.4 Global Musculoskeletal System Disorder Market Concentration Ratio 24
3.4.1 Global Musculoskeletal System Disorder Market Concentration Ratio (CR5 and HHI) 24
3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal System Disorder Revenue in 2023 25
3.5 Global Key Players of Musculoskeletal System Disorder Head office and Area Served 26
3.6 Global Key Players of Musculoskeletal System Disorder, Product 27
3.7 Global Key Players of Musculoskeletal System Disorder, Founded Date 28
3.8 Mergers & Acquisitions, Expansion Plans 29
4 Musculoskeletal System Disorder Breakdown Data by Type 31
4.1 Global Musculoskeletal System Disorder Historic Market Size by Type (2019-2024) 31
4.2 Global Musculoskeletal System Disorder Forecasted Market Size by Type (2025-2030) 32
5 Musculoskeletal System Disorder Breakdown Data by Application 33
5.1 Global Musculoskeletal System Disorder Historic Market Size by Application (2019-2024) 33
5.2 Global Musculoskeletal System Disorder Forecasted Market Size by Application (2025-2030) 34
6 North America 35
6.1 North America Musculoskeletal System Disorder Market Size (2019-2030) 35
6.2 North America Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030 35
6.3 North America Musculoskeletal System Disorder Market Size by Country (2019-2024) 36
6.4 North America Musculoskeletal System Disorder Market Size by Country (2025-2030) 36
6.5 United States 37
6.6 Canada 38
7 Europe 39
7.1 Europe Musculoskeletal System Disorder Market Size (2019-2030) 39
7.2 Europe Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030 39
7.3 Europe Musculoskeletal System Disorder Market Size by Country (2019-2024) 40
7.4 Europe Musculoskeletal System Disorder Market Size by Country (2025-2030) 40
7.5 Germany 41
7.6 France 42
7.7 U.K. 42
7.8 Italy 43
7.9 Russia 43
8 Asia-Pacific 44
8.1 Asia-Pacific Musculoskeletal System Disorder Market Size (2019-2030) 44
8.2 Asia-Pacific Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030 44
8.3 Asia-Pacific Musculoskeletal System Disorder Market Size by Region (2019-2024) 45
8.4 Asia-Pacific Musculoskeletal System Disorder Market Size by Region (2025-2030) 45
8.5 China 47
8.6 Japan 47
8.7 South Korea 48
8.8 Southeast Asia 48
8.9 India 49
8.10 Australia 49
9 Latin America 50
9.1 Latin America Musculoskeletal System Disorder Market Size (2019-2030) 50
9.2 Latin America Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030 50
9.3 Latin America Musculoskeletal System Disorder Market Size by Country (2019-2024) 51
9.4 Latin America Musculoskeletal System Disorder Market Size by Country (2025-2030) 51
9.5 Mexico 52
9.6 Brazil 53
10 Middle East & Africa 54
10.1 Middle East & Africa Musculoskeletal System Disorder Market Size (2019-2030) 54
10.2 Middle East & Africa Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030 54
10.3 Middle East & Africa Musculoskeletal System Disorder Market Size by Country (2019-2024) 55
10.4 Middle East & Africa Musculoskeletal System Disorder Market Size by Country (2025-2030) 55
10.5 Middle East 56
10.6 Africa 57
11 Key Players Profiles 58
11.1 AbbVie 58
11.1.1 AbbVie Company Details 58
11.1.2 AbbVie Business Overview 58
11.1.3 AbbVie Musculoskeletal System Disorder Introduction 59
11.1.4 AbbVie Revenue in Musculoskeletal System Disorder Business (2019-2024) 61
11.1.5 AbbVie Recent Development 61
11.2 Pfizer 63
11.2.1 Pfizer Company Details 63
11.2.2 Pfizer Business Overview 64
11.2.3 Pfizer Musculoskeletal System Disorder Introduction 64
11.2.4 Pfizer Revenue in Musculoskeletal System Disorder Business (2019-2024) 65
11.2.5 Pfizer Recent Development 66
11.3 Johnson & Johnson 66
11.3.1 Johnson & Johnson Company Details 67
11.3.2 Johnson & Johnson Business Overview 67
11.3.3 Johnson & Johnson Musculoskeletal System Disorder Introduction 68
11.3.4 Johnson & Johnson Revenue in Musculoskeletal System Disorder Business (2019-2024) 70
11.3.5 Johnson & Johnson Recent Development 71
11.4 Haleon 72
11.4.1 Haleon Company Details 72
11.4.2 Haleon Business Overview 72
11.4.3 Haleon Musculoskeletal System Disorder Introduction 74
11.4.4 Haleon Revenue in Musculoskeletal System Disorder Business (2019-2024) 74
11.4.5 Haleon Recent Development 75
11.5 Bayer 76
11.5.1 Bayer Company Details 76
11.5.2 Bayer Business Overview 76
11.5.3 Bayer Musculoskeletal System Disorder Introduction 77
11.5.4 Bayer Revenue in Musculoskeletal System Disorder Business (2019-2024) 78
11.6 Biogen 79
11.6.1 Biogen Company Details 79
11.6.2 Biogen Business Overview 79
11.6.3 Biogen Musculoskeletal System Disorder Introduction 80
11.6.4 Biogen Revenue in Musculoskeletal System Disorder Business (2019-2024) 81
11.6.5 Biogen Recent Development 81
11.7 Novartis 82
11.7.1 Novartis Company Details 82
11.7.2 Novartis Business Overview 82
11.7.3 Novartis Musculoskeletal System Disorder Introduction 83
11.7.4 Novartis Revenue in Musculoskeletal System Disorder Business (2019-2024) 83
11.8 Sanofi 84
11.8.1 Sanofi Company Details 84
11.8.2 Sanofi Business Overview 85
11.8.3 Sanofi Musculoskeletal System Disorder Introduction 86
11.8.4 Sanofi Revenue in Musculoskeletal System Disorder Business (2019-2024) 87
11.9 Sarepta Therapeutics 88
11.9.1 Sarepta Therapeutics Company Details 88
11.9.2 Sarepta Therapeutics Business Overview 88
11.9.3 Sarepta Therapeutics Musculoskeletal System Disorder Introduction 89
11.9.4 Sarepta Therapeutics Revenue in Musculoskeletal System Disorder Business (2019-2024) 89
11.9.5 Sarepta Therapeutics Recent Development 90
11.10 Merck & Co 90
11.10.1 Merck & Co Company Details 91
11.10.2 Merck & Co Business Overview 91
11.10.3 Merck & Co Musculoskeletal System Disorder Introduction 92
11.10.4 Merck & Co Revenue in Musculoskeletal System Disorder Business (2019-2024) 93
11.11 Nippon Shinyaku 93
11.11.1 Nippon Shinyaku Company Details 94
11.11.2 Nippon Shinyaku Business Overview 94
11.11.3 Nippon Shinyaku Musculoskeletal System Disorder Introduction 94
11.11.4 Nippon Shinyaku Revenue in Musculoskeletal System Disorder Business (2019-2024) 95
11.11.5 Nippon Shinyaku Recent Development 96
11.12 Bristol-Myers Squibb 96
11.12.1 Bristol-Myers Squibb Company Details 96
11.12.2 Bristol-Myers Squibb Business Overview 97
11.12.3 Bristol-Myers Squibb Musculoskeletal System Disorder Introduction 98
11.12.4 Bristol-Myers Squibb Revenue in Musculoskeletal System Disorder Business (2019-2024) 99
11.12.5 Bristol-Myers Squibb Recent Development 100
11.13 Roche 101
11.13.1 Roche Company Details 101
11.13.2 Roche Business Overview 101
11.13.3 Roche Musculoskeletal System Disorder Introduction 102
11.13.4 Roche Revenue in Musculoskeletal System Disorder Business (2019-2024) 102
11.13.5 Roche Recent Development 103
11.14 UCB 104
11.14.1 UCB Company Details 104
11.14.2 UCB Business Overview 104
11.14.3 UCB Musculoskeletal System Disorder Introduction 105
11.14.4 UCB Revenue in Musculoskeletal System Disorder Business (2019-2024) 105
11.15 Stryker 106
11.15.1 Stryker Company Details 106
11.15.2 Stryker Business Overview 107
11.15.3 Stryker Musculoskeletal System Disorder Introduction 108
11.15.4 Stryker Revenue in Musculoskeletal System Disorder Business (2019-2024) 109
11.15.5 Stryker Recent Development 109
11.16 Zimmer Biomet 110
11.16.1 Zimmer Biomet Company Details 110
11.16.2 Zimmer Biomet Business Overview 111
11.16.3 Zimmer Biomet Musculoskeletal System Disorder Introduction 112
11.16.4 Zimmer Biomet Revenue in Musculoskeletal System Disorder Business (2019-2024) 113
11.16.5 Zimmer Biomet Recent Development 114
11.17 Smith & Nephew 116
11.17.1 Smith & Nephew Company Details 116
11.17.2 Smith & Nephew Business Overview 117
11.17.3 Smith & Nephew Musculoskeletal System Disorder Introduction 117
11.17.4 Smith & Nephew Revenue in Musculoskeletal System Disorder Business (2019-2024) 118
11.18 Globus Medical 119
11.18.1 Globus Medical Company Details 119
11.18.2 Globus Medical Business Overview 120
11.18.3 Globus Medical Musculoskeletal System Disorder Introduction 121
11.18.4 Globus Medical Revenue in Musculoskeletal System Disorder Business (2019-2024) 125
11.18.5 Globus Medical Recent Development 125
11.19 Medtronic 126
11.19.1 Medtronic Company Details 126
11.19.2 Medtronic Business Overview 127
11.19.3 Medtronic Musculoskeletal System Disorder Introduction 128
11.19.4 Medtronic Revenue in Musculoskeletal System Disorder Business (2019-2024) 129
11.19.5 Medtronic Recent Development 130
11.20 B Braun 131
11.20.1 B Braun Company Details 131
11.20.2 B Braun Business Overview 132
11.20.3 B Braun Musculoskeletal System Disorder Introduction 133
11.20.4 B Braun Revenue in Musculoskeletal System Disorder Business (2019-2024) 136
11.20.5 B Braun Recent Development 137
11.21 Acumed 138
11.21.1 Acumed Company Details 138
11.21.2 Acumed Business Overview 138
11.21.3 Acumed Musculoskeletal System Disorder Introduction 139
11.21.4 Acumed Revenue in Musculoskeletal System Disorder Business (2019-2024) 141
11.21.5 Acumed Recent Development 141
11.22 Orthofix 142
11.22.1 Orthofix Company Details 142
11.22.2 Orthofix Business Overview 143
11.22.3 Orthofix Musculoskeletal System Disorder Introduction 143
11.22.4 Orthofix Revenue in Musculoskeletal System Disorder Business (2019-2024) 145
11.22.5 Orthofix Recent Development 146
11.23 Arthrex 146
11.23.1 Arthrex Company Details 146
11.23.2 Arthrex Business Overview 147
11.23.3 Arthrex Musculoskeletal System Disorder Introduction 148
11.23.4 Arthrex Revenue in Musculoskeletal System Disorder Business (2019-2024) 149
11.24 MicroPort 150
11.24.1 MicroPort Company Details 150
11.24.2 MicroPort Business Overview 151
11.24.3 MicroPort Musculoskeletal System Disorder Introduction 152
11.24.4 MicroPort Revenue in Musculoskeletal System Disorder Business (2019-2024) 154
11.25 WEGO 154
11.25.1 WEGO Company Details 155
11.25.2 WEGO Business Overview 155
11.25.3 WEGO Musculoskeletal System Disorder Introduction 156
11.25.4 WEGO Revenue in Musculoskeletal System Disorder Business (2019-2024) 156
12 Analyst's Viewpoints/Conclusions 158
13 Appendix 160
13.1 Research Methodology 160
13.1.1 Methodology/Research Approach 160
13.1.2 Data Source 163
13.2 Author Details 166
13.3 Disclaimer 166